Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Plains GP Holdings, L.P.COMM(PAGP) | 1,272,360 | 1,272,360 | 0 | $30.18M | $30.88M | 16.16% | +$699.8K |
| Achieve Life Sciences IncCOMM | 3,786,425 | 4,034,018 | +247,593 | $11.37M | $26.34M | 13.79% | +$14.97M |
| Corcept Therapeutics IncorporatedCOMM(CORT) | 147,828 | 136,499 | -11,329 | $6.02M | $11.87M | 6.21% | +$5.85M |
| Phathom Pharmaceuticals, Inc.COMM(PHAT) | 841,272 | 1,050,358 | +209,086 | $9.35M | $11.40M | 5.96% | +$2.04M |
| Delcath Systems, Inc.COMM(DCTH) | 979,698 | 871,460 | -108,238 | $9.16M | $10.97M | 5.74% | +$1.81M |
| Milestone Pharmaceuticals Inc.COMM(MIST) | 4,118,321 | 7,429,590 | +3,311,269 | $5.08M | $9.96M | 5.21% | +$4.87M |
| COMPASS Pathways plcADRS(CMPS) | 742,049 | 573,086 | -168,963 | $4.12M | $8.11M | 4.24% | +$3.99M |
| Kyverna Therapeutics, Inc.COMM(KYTX) | 644,421 | 883,198 | +238,777 | $5.59M | $7.87M | 4.12% | +$2.28M |
| Artiva Biotherapeutics, Inc.COMM(ARTV) | 146,369 | 696,436 | +550,067 | $949.8K | $6.76M | 3.54% | +$5.81M |
| Abeona Therapeutics Inc.COMM(ABEO) | 1,329,899 | 983,070 | -346,829 | $6.01M | $6.08M | 3.18% | +$67.4K |
| Aquestive Therapeutics InCOMM | 710,988 | 1,442,397 | +731,409 | $2.95M | $6.00M | 3.14% | +$3.05M |
| Palisade Bio, Inc.COMM(PALI) | 1,115,000 | 2,582,388 | +1,467,388 | $2.00M | $5.40M | 2.82% | +$3.40M |
| Immunic, Inc.COMM(IMUX) | 0 | 325,022 | +325,022 | $0 | $5.00M | 2.61% | +$5.00M |
| Inventiva S.A.COMM(IVA) | 724,678 | 1,281,212 | +556,534 | $3.99M | $4.84M | 2.53% | +$848.4K |
| SAB Biotherapeutics, Inc.COMM(SABS) | 1,012,790 | 1,076,578 | +63,788 | $3.89M | $4.20M | 2.20% | +$312.2K |
| Orchestra BioMed Holdings, Inc.COMM(OBIO) | 896,701 | 896,701 | 0 | $3.83M | $3.87M | 2.02% | +$38.5K |
| Celldex Therapeutics, Inc.COMM(CLDX) | 131,364 | 103,695 | -27,669 | $4.14M | $3.86M | 2.02% | -$276.6K |
| Zevra Therapeutics, Inc.COMM(ZVRA) | 282,418 | 253,544 | -28,874 | $2.64M | $3.64M | 1.90% | +$995.0K |
| Ocular Therapeutix, Inc.COMM(OCUL) | 382,375 | 357,966 | -24,409 | $3.23M | $3.52M | 1.84% | +$289.1K |
| 4d Molecular Therapeutics InCOMM | 380,420 | 252,654 | -127,766 | $3.58M | $3.36M | 1.76% | -$220.9K |
| Ovid Therapeutics Inc.COMM(OVID) | 921,457 | 1,115,538 | +194,081 | $2.04M | $3.00M | 1.57% | +$963.0K |
| EyePoint, Inc.COMM(EYPT) | 215,825 | 191,745 | -24,080 | $2.79M | $2.74M | 1.43% | -$47.0K |
| Upstream Bio, Inc.COMM(UPB) | 341,779 | 350,389 | +8,610 | $3.10M | $2.42M | 1.27% | -$675.4K |
| Scynexis IncCOMM | 0 | 543,478 | +543,478 | $0 | $2.21M | 1.16% | +$2.21M |
| Silence Therapeutics plcADRS(SLN) | 0 | 191,733 | +191,733 | $0 | $2.11M | 1.10% | +$2.11M |
| LeonaBio, Inc.COMM(LONA) | 149,279 | 149,279 | 0 | $1.50M | $1.37M | 0.72% | -$123.9K |
| Maze Therapeutics, Inc.COMM(MAZE) | 43,798 | 43,798 | 0 | $1.31M | $1.31M | 0.68% | -$438 |
| Corvus Pharmaceuticals, Inc.COMM(CRVS) | 85,791 | 70,380 | -15,411 | $1.25M | $1.05M | 0.55% | -$199.6K |
| Sagimet Biosciences Inc.COMM(SGMT) | 0 | 125,878 | +125,878 | $0 | $973.0K | 0.51% | +$973.0K |
| Aldeyra Therapeutics, Inc.(ALDX) | 730,606 | 0 | -730,606 | $1.23M | $0 | — | -$1.23M |
| Coherus Oncology, Inc.(CHRS) | 1,420,550 | 0 | -1,420,550 | $2.41M | $0 | — | -$2.41M |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 209,493 | 0 | -209,493 | $553.9K | $0 | — | -$553.9K |
| Evommune, Inc.(EVMN) | 55,664 | 0 | -55,664 | $1.28M | $0 | — | -$1.28M |
| Immunic, Inc.(IMUX) | 2,344,779 | 0 | -2,344,779 | $2.62M | $0 | — | -$2.62M |
| Kalaris Therapeutics, Inc.(KLRS) | 295,771 | 0 | -295,771 | $1.72M | $0 | — | -$1.72M |
| Nuvation Bio Inc.CL A(NUVB) | 329,296 | 0 | -329,296 | $1.41M | $0 | — | -$1.41M |
| Oculis Holding AG(OCS) | 122,223 | 0 | -122,223 | $3.28M | $0 | — | -$3.28M |
| Satellos Bioscience Inc.(MSLE) | 10,145 | 0 | -10,145 | $57.1K | $0 | — | -$57.1K |
| Trevi Therapeutics, Inc.(TRVI) | 223,802 | 0 | -223,802 | $2.65M | $0 | — | -$2.65M |
| uniQure N.V.SHS(QURE) | 104,772 | 0 | -104,772 | $1.71M | $0 | — | -$1.71M |
| Viridian Therapeutics, Inc.(VRDN) | 210,163 | 0 | -210,163 | $4.09M | $0 | — | -$4.09M |
| Vor Biopharma Inc.(VOR) | 314,543 | 0 | -314,543 | $5.59M | $0 | — | -$5.59M |